PDF
Private Sector's Critical Role in Biomedical Innovation
![](/sites/default/files/images/toolkit/BIO-Analysis-NIH-Grants-page1.jpg)
Private Sector's Critical Role in Biomedical Innovation
There is a misguided perception that NIH funding, not private market investment, is largely responsible for the creation and approval of new therapies. A new study by Vital Transformation¹ tests that hypothesis by tracking more than 20,000 patents linked to NIH grant over a 20 year period, identifying those associated with clinical trials and approved medicines, and quantifying the public and private investments made for those investigational and approved medicines.
VIEW DETAILS
![](/sites/default/files/images/toolkit/BIO-Analysis-NIH-Grants-page2.jpg)
Private Sector's Critical Role in Biomedical Innovation
There is a misguided perception that NIH funding, not private market investment, is largely responsible for the creation and approval of new therapies. A new study by Vital Transformation¹ tests that hypothesis by tracking more than 20,000 patents linked to NIH grant over a 20 year period, identifying those associated with clinical trials and approved medicines, and quantifying the public and private investments made for those investigational and approved medicines.
VIEW DETAILS